Back to Results
First PageMeta Content
Pharmaceutical industry / Pharmacy / Pharmaceuticals policy / Biotechnology / Immunogenicity / Immunology / European Federation of Pharmaceutical Industries and Associations / Biopharmaceutical / Novartis / Sanofi / Pharmaceutical drug / Drug development


ABIRISK Making novel drugs safer for patients A growing number of medicines are based on biological molecules such as proteins and monoclonal antibodies. These novel drugs have resulted in new, more effective treatments
Add to Reading List

Document Date: 2012-11-23 07:10:19


Open Document

File Size: 124,66 KB

Share Result on Facebook